Press Releases SyneuRx International (Taiwan) Corp.

Equities

End-of-day quote Taipei Exchange Other stock markets 06:00:00 2023-01-05 pm EST			5-day change	1st Jan Change
17.2 ^TWD	-.--%		-.--%	-.--%

Apr. 29	SyneuRx International Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	SyneuRx International Corp. Reports Earnings Results for the Half Year Ended June 30, 2023	CI

SyneuRx Announces Final Results of Phase 2 Clinical Trial of COVID-19 Oral Antiviral Candidate Pentarlandir® (SNB01)	22-07-31	BU
SyneuRx Reaches Target Enrollment in Phase 2 Clinical Trial of COVID-19 Oral Antiviral Candidate Pentarlandir® (SNB01)	22-04-13	BU

No results for this search